For three decades, Viagra was known almost exclusively for one medical indication: the treatment of erectile dysfunction.. Now, a group of researchers believe the drug could have a completely different and potentially much broader application: help make it harder for cancer to spread throughout the body.
The hypothesis arises from a study published in the journal Cancer Research and carried out by scientists from Weizmann Institute of Sciences, in Israel, led by Yarden Ariav under the direction of researcher Ayelet Erez. The results suggest that Sildenafil, the active ingredient in Viagra, interferes with a biological mechanism that tumor cells use to form metastases.
Metastasis, that is, the ability of cancer cells to break away from the original tumor, travel through the body and invade other organs, is one of the main causes of death associated with cancer. That’s why, Finding ways to prevent this process is one of the main objectives of oncological research.
According to the authors, sildenafil does not act directly on the tumor, but about one of the resources that cancer cells need to expand: cholesterol.
Although it is often associated with cardiovascular diseases, cholesterol performs fundamental functions in the body. It is an essential component of cell membranes and participates in numerous biological processes. Tumor cells that try to migrate and colonize other tissues are especially dependent on this resource..
Researchers found that sildenafil alters the ability of cancer cells to use that cholesterol.
The mechanism begins with the usual action of the drug. Sildenafil blocks an enzyme known as phosphodiesterase type 5, or PDE5. This inhibition increases the levels of a molecule called cGMP, which is responsible for the effect by which the drug promotes blood circulation and is used to treat erectile dysfunction.
However, the team found an additional effect that had gone unnoticed until now. Increased cGMP also interferes with a protein called NPC1responsible for the transport of cholesterol within cells.
As a consequence, Cholesterol becomes trapped in cellular compartments called lysosomes and is no longer available for other functions.. Tumor cells appear to be particularly vulnerable to that reduction in supply.
“We demonstrate that PDE5 inhibitors, including sildenafil, reduce cholesterol availability and alter the migration and metastatic capacity of cancer cells,” the authors noted in the work.
“Cancer cells showed increased sensitivity to alteration of cholesterol transport”the researchers wrote, describing why this mechanism especially affects cells capable of forming metastases.
To reach this conclusion, combined various types of evidence.
On the one hand, they carried out experiments in mice with cancer and observed that the alteration of cholesterol transport reduced the capacity for metastasis formation.
They also worked with human tumor cells in the laboratory and verified that blocking access to cholesterol caused similar effects. But the most striking aspect of the study emerged outside the laboratory.
The scientists analyzed medical information accumulated over approximately 20 years corresponding to some five million members of the Israeli Clalit health system. Upon reviewing the medical records, they found that Cancer patients who received sildenafil for other medical indications had significantly better survival than those who did not use it.
The benefit was even greater when the drug was combined with statinsthe family of drugs used to reduce cholesterol production in the body.
That observation also fits with the experimental results. While the sildenafil makes it difficult for tumor cells to use available cholesterol, statins reduce the production of new cholesterol. According to the researchers, both strategies could complement each other and reinforce the antimetastatic effect.
“The combination of sildenafil with statins produced additive antimetastatic effects by simultaneously blocking cholesterol availability and synthesis”the authors noted.
The authors described this combination as a way to simultaneously attack two pathways that allow cancer cells to access that resource.
However, they cautioned that it is still too early to consider Viagra as a cancer treatment.
The improvement seen in medical records comes from an observational analysis and not from a clinical trial specifically designed to evaluate this effect. Therefore, the researchers cannot say that the drug was the direct cause of the increased survival observed.
